Tanshinone for polycystic ovary syndrome: A protocol of systematic review and meta-analysis

BACKGROUNDS: Polycystic ovary syndrome (PCOS) constitutes an endocrine and metabolic disorder characterized by hyperandrogenemia, ovulation disorders, and polycystic ovary. Existing therapy is low efficacy and has significant side effects. In traditional Chinese medicine, tanshinone was used for PCO...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yijiao, Xia, Yue, Peng, Xia, Xie, Jiani, Liu, Honglin, Ni, Xiaorong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837902/
https://www.ncbi.nlm.nih.gov/pubmed/33546053
http://dx.doi.org/10.1097/MD.0000000000024287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837902/
https://www.ncbi.nlm.nih.gov/pubmed/33546053
http://dx.doi.org/10.1097/MD.0000000000024287

Ejemplares similares